Home › Research › Prevention and risk
Sleep apnea and the risk of dementia: A systematic review and meta-analysis
Guay-Gagnon M, Vat S, Forget MF, Tremblay-Gravel M, Ducharme S, Nguyen QD, et al.. Journal of Sleep Research, 2022-04-02
Topic: Risk, prevention and care in population studies
Plain-language summary
Sleep apnea (SA) is potentially a modifiable risk factor for dementia. However, its associations to specific aetiologies of dementia remain uncertain. A systematic review and meta-analysis of cohort studies investigating the association between sleep apnea and specific aetiologies of dementia, including Alzheimer's disease (AD), Parkinson's disease (PD), Lewy body dementia (LBD), vascular dementia (VaD), and frontotemporal dementia (FTD) was performed. The use of biomarkers to support clinical diagnoses in eligible studies was collected. Eleven studies were included, comprising 1,333,424 patients. Patients with sleep apnea had an increased risk of developing any type of neurocognitive disorder (HR: 1.43 [95% CI 1.26-1.62]), Alzheimer's disease (HR: 1.28 [95% CI 1.16-1.41]), and Parkinson's disease (HR: 1.54 [95% CI 1.30-1.84]). No statistically significant association was found for vascular dementia. One study reported a two-fold increased risk for Lewy body dementia (HR: 2.06 [95% CI 1.45-2.91]). No studies investigated the risk for frontotemporal dementia and none of the studies reported results pertaining to biomarkers. Sleep apnea is associated with a significantly increased risk of dementia, particularly for Alzheimer's disease and Parkinson's disease, but not for vascular dementia. Future studies should look at the impact of sleep apnea on specific dementia biomarkers.
What this study adds
Evidence grade: Moderate
This is a pooled review of 1,333,424 participants. This analysis of over a million patients found that people with sleep apnea had a higher risk of developing Alzheimer's disease and Parkinson's disease, but no significant link was found for vascular dementia. Reported effect size: HR 1.43 (95% CI 1.26-1.62) for any neurocognitive disorder; Alzheimer's HR 1.28 (1.16-1.41).
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Guay-Gagnon, M., Vat, S., Forget, M. F., Tremblay-Gravel, M., Ducharme, S., Nguyen, Q. D., et al. (2022). Sleep apnea and the risk of dementia: A systematic review and meta-analysis. Journal of Sleep Research. https://doi.org/10.1111/jsr.13589
Vancouver
Guay-Gagnon M, Vat S, Forget MF, Tremblay-Gravel M, Ducharme S, Nguyen QD, et al. Sleep apnea and the risk of dementia: A systematic review and meta-analysis. Journal of Sleep Research. 2022. doi:10.1111/jsr.13589. PMID: 35366021.
BibTeX
@article{guaygagnon2022-35366021,
author = {Guay-Gagnon, M. and Vat, S. and Forget, M. F. and Tremblay-Gravel, M. and Ducharme, S. and Nguyen, Q. D. and others},
title = {{Sleep apnea and the risk of dementia: A systematic review and meta-analysis}},
journal = {Journal of Sleep Research},
year = {2022},
doi = {10.1111/jsr.13589},
pmid = {35366021},
url = {https://doi.org/10.1111/jsr.13589}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Patients with sleep apnea had an increased risk of developing any type of neurocognitive disorder (HR: 1.43 [95% CI 1.26-1.62]), Alzheimer's disease (HR: 1.28 [95% CI 1.16-1.41]), and Parkinson's disease (HR: 1.54 [95% CI 1.30-1.84]).
- No statistically significant association was found for vascular dementia.
- One study reported a two-fold increased risk for Lewy body dementia (HR: 2.06 [95% CI 1.45-2.91]).
- No studies investigated the risk for frontotemporal dementia and none of the studies reported results pertaining to biomarkers.
- Sleep apnea is associated with a significantly increased risk of dementia, particularly for Alzheimer's disease and Parkinson's disease, but not for vascular dementia.
Why it matters
This analysis of over a million patients found that people with sleep apnea had a higher risk of developing Alzheimer's disease and Parkinson's disease, but no significant link was found for vascular dementia. Because sleep apnea can be treated, it is a potentially modifiable risk factor, but the review found no studies that looked at dementia biomarkers.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designmeta-analysis
- Participants1,333,424
- Effect sizeHR 1.43 (95% CI 1.26-1.62) for any neurocognitive disorder; Alzheimer's HR 1.28 (1.16-1.41)
- Evidence strengthModerate
Limitations
Observational; sleep apnoea often from diagnostic codes; no data on whether treatment changes risk; heterogeneity across cohorts.
How this study scored 70/100
Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. We have no data on free to read, so that was left out: it earned 69 of the 98 points we could judge it on, which is 70 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Sleep Research) |
| Journal's citation record | 2 / 4 | Journal of Sleep Research: journal h-index 177 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 1,333,424 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 5 / 7 | Cited 105 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 17.5 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 3 / 6 | Cited 3.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 8 other studies in this library |
| Still being cited | 3 / 4 | Cited 93 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Philippe Desmarais: h-index 15 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | McGill University: institution h-index 1,373 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 6 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35366021) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 69 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 69 of the 98 points we could judge it on is 70 out of 100. |
| Total | 70 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
8 studies in the alzhub library list this one in their references.
Related studies in Prevention and risk from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.